Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
11/10/2004 | EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors |
11/10/2004 | EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals |
11/10/2004 | EP1474395A1 Nicotinamide derivates useful as p38 inhibitors |
11/10/2004 | EP1474391A1 Water soluble phenylglycine derivatives |
11/10/2004 | EP1474142A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof |
11/10/2004 | EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g) |
11/10/2004 | EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
11/10/2004 | EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
11/10/2004 | EP1474124A1 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood |
11/10/2004 | EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
11/10/2004 | EP1474093A2 Granzyme b inhibitors |
11/10/2004 | EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
11/10/2004 | EP0658206B1 Inhibitor resistant serine proteases |
11/10/2004 | EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE |
11/10/2004 | CN1545522A Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
11/10/2004 | CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity |
11/10/2004 | CN1544477A Urushi polysaccharide sulfation and its preparation method and uses |
11/10/2004 | CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity |
11/10/2004 | CN1544088A Immediate release tablet |
11/10/2004 | CN1544086A Application of apolipoprotein A-I in the preparing process for medicine capable of resisting endotoxin and inhibiting cytokine release |
11/10/2004 | CN1544028A Leukopenia treating Chinese traditional medicine |
11/10/2004 | CN1543979A Preparing process of anticoagulant konjak glucomanan sulfate |
11/10/2004 | CN1543969A Application of Japanese raspberry saponin in the treatment of cerebral ischemia disease |
11/10/2004 | CN1543955A Freeze-dried dipyrimadole preparation for injection and prepartion thereof |
11/10/2004 | CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof |
11/10/2004 | CN1543860A Method for extracting bamboo leaf flavonoid and foodstuff and drug containing the same |
11/10/2004 | CN1175105C Purification of vitamin-K dependent proteins by membrane chromatography |
11/10/2004 | CN1174984C Carbamoyl tetrahydropyridine derivatives |
11/09/2004 | US6815534 Tissue plasminogen activator-like protease |
11/09/2004 | US6815463 For therapy of disease of cellular hyperproliferation in a subject |
11/09/2004 | US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
11/09/2004 | US6815458 Nervous system disorders |
11/09/2004 | US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
11/04/2004 | WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE |
11/04/2004 | WO2004094407A1 Five-membered heterocyclic derivative |
11/04/2004 | WO2004094404A1 4-imidazolin-2-one compounds |
11/04/2004 | WO2004093912A1 Preventive and/or therapeutic agent for neutrophil inflammation disease |
11/04/2004 | WO2004093881A2 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
11/04/2004 | WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
11/04/2004 | WO2004069254A3 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
11/04/2004 | WO2003103662A3 Inhibitors of glycoprotein vi |
11/04/2004 | WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization |
11/04/2004 | WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
11/04/2004 | US20040220415 Benzofuran derivatives |
11/04/2004 | US20040220408 As anti-proliferative agents, therapy |
11/04/2004 | US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
11/04/2004 | US20040220388 Novel heterodimeric fusion proteins |
11/04/2004 | US20040220241 Substituted biphenyl derivatives |
11/04/2004 | US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide |
11/04/2004 | US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders |
11/04/2004 | US20040220143 Oral delivery of macromolecules |
11/04/2004 | US20040220133 Composition and method for inhibiting platelet aggregation |
11/04/2004 | US20040220106 Modified vitamin K-dependent polypeptides |
11/04/2004 | US20040220092 G-protein coupled receptors |
11/04/2004 | US20040219207 Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases |
11/04/2004 | US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
11/04/2004 | CA2523157A1 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression ofthrombin receptors |
11/04/2004 | CA2522743A1 Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
11/04/2004 | CA2522536A1 Five-membered heterocyclic derivative |
11/04/2004 | CA2521504A1 Method and kit for controlling bleeding |
11/03/2004 | EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases |
11/03/2004 | EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
11/03/2004 | EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
11/03/2004 | EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier |
11/03/2004 | EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia |
11/03/2004 | EP1472273A2 Compositions and methods for the treatement of immune related diseases |
11/03/2004 | EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
11/03/2004 | EP1472255A1 Aza-arylpiperazines |
11/03/2004 | EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
11/03/2004 | EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
11/03/2004 | EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto |
11/03/2004 | EP1472209A2 Lipoxin a4 analogs |
11/03/2004 | EP1472021A2 Compositions including ammonia oxidizing bacteria and methods of using same |
11/03/2004 | EP1471933A1 Albumin-fused anti-angiogenesis peptides |
11/03/2004 | EP1471928A1 Hiv inhibiting proteins |
11/03/2004 | EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
11/03/2004 | EP1471924A1 Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
11/03/2004 | EP1471870A2 Use of lipid conjugates in the treatment of disease |
11/03/2004 | EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules |
11/03/2004 | EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
11/03/2004 | EP1339716B1 lactam-substituted pyrazolopyridine derivatives |
11/03/2004 | EP1261609B1 Triazolotriazinones and the use thereof |
11/03/2004 | EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
11/03/2004 | EP1191028B1 Tricyclic compounds having spiro union |
11/03/2004 | EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors |
11/03/2004 | EP1169338B1 Low-molecular inhibitors of complement proteases |
11/03/2004 | EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues |
11/03/2004 | CN1543461A Melanocortin receptor ligands |
11/03/2004 | CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
11/03/2004 | CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
11/03/2004 | CN1543362A Medical products comprising a haemocompatible coating, production and use thereof |
11/03/2004 | CN1543344A Aryl(or hetero aryl) aza cyclopentadienyl carbinol ramifications for treating urinary incontinence |
11/03/2004 | CN1542135A Preparation and use for phospholipase A2 congener from Agkistrodon blomhoffii Ussurensis of Changbai Mountains and genes encoding same |
11/03/2004 | CN1542022A Carboxybutyryl chitosan sulfuric ester and preparation method and use thereof |
11/03/2004 | CN1542021A Sodium alginate sulfuric ester and preparation method and use thereof |
11/03/2004 | CN1541683A Antithrombotic Qilong Capsule |
11/03/2004 | CN1541676A Health care medicine for enriching blood in puerperium and its preparation and uses |
11/03/2004 | CN1541654A Donkey-hide gelatin freeze-dry powder capsule and its process |
11/03/2004 | CN1541647A Di-acetyl-aminoethyl-ethylenediamine powder injection and its preparation method |
11/03/2004 | CN1173958C Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application |